A proposed $7.4B settlement, which still needs court approval, would resolve states' litigation against makers and marketers of opioid OxyContin.

Funds from the national opioid settlement are paying for addiction recovery programs at the Aiken County jail, including ...

Utah and all 54 other eligible jurisdictions agreed to sign onto a settlement agreement with Purdue Pharma and the Sackler ...

T he $7.4 billion settlement involves Purdue Pharma, the maker of OxyContin, and the Sackler family, who own the company.

Teva Pharmaceutical Industries recently made headlines by agreeing to a $2.25 million settlement in a class-action lawsuit concerning Effexor XR®. This legal development, although not directly ...

A group of health insurers has filed a lawsuit against Corcept Therapeutics (NASDAQ:CORT) in California, accusing the rare disease drugmaker of blocking Teva Pharmaceutical (NYSE:TEVA) from ...

Amicus will grant Teva a license to market a generic version of Galafold in the US beginning in January 2037. The litigation will continue against Aurobindo as the remaining active party ...

The U.S. has had its eye on Teva’s Copaxone dealings since the summer of 2020 when the Justice Department filed a false claims lawsuit detailing the alleged kickbacks. The case never went to ...

The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals, one of the defendants in the city’s ongoing lawsuit against drug manufacturers and distributors accused of ...

The DOJ lawsuit against Teva, filed in 2020, alleges the company faces potential triple damages under the False Claims Act. Unlock your all-in-one trading dashboard with real-time alerts ...

Teva Pharmaceutical Industries Ltd (TEVA.TA), opens new tab said it is in active talks to settle a U.S. Department of Justice lawsuit alleging it used charities that help cover Medicare patients ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...